Melphalan and Prednisone (MP) versus Vincristine, BCNU, Adriamycin, Melphalan and Dexamethasone (VBAM Dex) Induction Chemotherapy and Interferon Maintenance Treatment in Multiple Myeloma

التفاصيل البيبلوغرافية
العنوان: Melphalan and Prednisone (MP) versus Vincristine, BCNU, Adriamycin, Melphalan and Dexamethasone (VBAM Dex) Induction Chemotherapy and Interferon Maintenance Treatment in Multiple Myeloma
المؤلفون: M. Gramatzki, J.T. Fischer, I.-M. von Broen, R. Henke, J. Oertel, E. Schäfer, J. Selbach, R. Coldewey, H. Wagner, R. Hein, H. J. Braun, Deicher H, D. Peest, M. Planker, C. Tirier, R. Leo, H. Bartels, W. Stenzinger, C.R. Meier, E. Schumacher, L. Hoffmann, M. Stennes, K. Schumacher, E. D. Kreuser, W. D. Maier, J. Wysk, R. Bartl, H. J. Weh, H.M. Reinhold
المصدر: Oncology Research and Treatment. 13:458-460
بيانات النشر: S. Karger AG, 1990.
سنة النشر: 1990
مصطلحات موضوعية: Oncology, Melphalan, Cancer Research, medicine.medical_specialty, Vincristine, business.industry, Induction chemotherapy, Hematology, medicine.disease, Prednisone, Interferon, Internal medicine, Multicenter trial, medicine, business, Dexamethasone, Multiple myeloma, medicine.drug
الوصف: 277 untreated multiple myeloma patients of stage I (n = 33), II (n = 106) and III (n = 138) entered the study. Patients of stage II presenting a progressive tumor (n = 64) initially or during observat
تدمد: 2296-5262
2296-5270
DOI: 10.1159/000216820
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::450d7fe7266909265fbcef22491e1292
https://doi.org/10.1159/000216820
Rights: CLOSED
رقم الانضمام: edsair.doi...........450d7fe7266909265fbcef22491e1292
قاعدة البيانات: OpenAIRE
الوصف
تدمد:22965262
22965270
DOI:10.1159/000216820